imagej (fiji) software Search Results


90
GraphPad Software Inc fiji (imagej)
Fiji (Imagej), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pm37321224-439-210-215?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
fiji (imagej) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Schmid GmbH imagej software
Imagej Software, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/10__7554_slash_elife__24888-370-5-18?v=Schmid+GmbH
Average 90 stars, based on 1 article reviews
imagej software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Seikagaku corporation imagej fiji software
Imagej Fiji Software, supplied by Seikagaku corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pm38577652-200-17-6?v=Seikagaku+corporation
Average 90 stars, based on 1 article reviews
imagej fiji software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc fiji implementation imagej
Fiji Implementation Imagej, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pmc06601011-135-8-15?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
fiji implementation imagej - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CH Instruments imagej fiji software
Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by <t>ImageJ</t> <t>(FiJI)</t> using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).
Imagej Fiji Software, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pmc08629005-222-21-25?v=CH+Instruments
Average 90 stars, based on 1 article reviews
imagej fiji software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Siemens AG fiji imagej software
Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by <t>ImageJ</t> <t>(FiJI)</t> using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).
Fiji Imagej Software, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pmc11589265-1-13-7?v=Siemens+AG
Average 90 stars, based on 1 article reviews
fiji imagej software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Hartenstein GmbH nih imagej/fiji software
Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by <t>ImageJ</t> <t>(FiJI)</t> using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).
Nih Imagej/Fiji Software, supplied by Hartenstein GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/us11800859-252-4-33?v=Hartenstein+GmbH
Average 90 stars, based on 1 article reviews
nih imagej/fiji software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Hamamatsu imagej (fiji) software
Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by <t>ImageJ</t> <t>(FiJI)</t> using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).
Imagej (Fiji) Software, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pm37399862-114-18-24?v=Hamamatsu
Average 90 stars, based on 1 article reviews
imagej (fiji) software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Broad Institute Inc fiji (imagej) software
Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by <t>ImageJ</t> <t>(FiJI)</t> using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).
Fiji (Imagej) Software, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pm37224534-87-5-10?v=Broad+Institute+Inc
Average 90 stars, based on 1 article reviews
fiji (imagej) software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc imagej 1.52as fiji
Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by <t>ImageJ</t> <t>(FiJI)</t> using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).
Imagej 1.52as Fiji, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pm40280124-246-10-11?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
imagej 1.52as fiji - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc fiji package imagej 1.52p software
Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by <t>ImageJ</t> <t>(FiJI)</t> using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).
Fiji Package Imagej 1.52p Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagej+%28fiji%29+software/pm33819839-110-8-24?v=GraphPad+Software+Inc
Average 90 stars, based on 1 article reviews
fiji package imagej 1.52p software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by ImageJ (FiJI) using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).

Journal: Journal of Developmental Biology

Article Title: Zebrafish Paralogs brd2a and brd2b Are Needed for Proper Circulatory, Excretory and Central Nervous System Formation and Act as Genetic Antagonists during Development

doi: 10.3390/jdb9040046

Figure Lengend Snippet: Anti-Brd2b peptide antibody detects major protein products in zebrafish embryos and oocytes, that are reduced in brd2b MO morphants. ( A , B ) Western blot ( A ) of total ovary (ov) and staged embryos (4 h, 24 h, 48 h) probed with anti-Brd2b peptide antibody. Blot was prestained ( B ) to assess total protein and relative loading across lanes. Total ovary samples often show a large amount of high molecular weight staining corresponding to yolk proteins that make up predominant products in this tissue; nevertheless, these do not interfere with the detection of Brd2b. A product over 150 kD is consistently detected in ovaries and 48 hpf embryos and sometimes faintly in 4 and 24 hpf embryos (top arrowheads in A); a product between 50 and 75 kD is also consistently detected in 48 hpf embryos (bottom arrowhead) and sometimes also in 4 hpf and 24 hpf embryos (see ). ( C , D ) Duplicate blot of A probed with anti-Brd2b peptide antibody in the presence of peptide antigen for peptide competition assay ( C ). The blot was prestained ( D ) to assess total protein and relative loading across lanes before antibody + peptide incubation. Peptide competition prevents all antibody signals on blot ( C ), supporting specificity of antibody for Brd2b epitope. Prestaining of blot using Memcode protein stain ( D ) assures that lack of anti-Brd2b signal in C is due to peptide competition rather than lack of protein in lanes. ( E ) Immunohistochemical analysis of staged oocytes (I–IV) and higher magnification stage IV oocyte (IV) using anti-Brd2b peptide antibodies, and showing eventual localization to the micropyle and future animal pole. ( F , G ) Western blot to assess efficacy of brd2b MO morpholino knockdown. Twenty-four hours post-fertilization embryo treatment groups: uninjected (wt), control 5-base mismatch morpholino-injected (mis5), and brd2b MO1-injected (2bMO), probed with anti-Brd2b peptide antibody ( F ). The blot was prestained ( G ) to assess total loading and relative loading across lanes. When relative loading is taken into account, there is a 3-fold reduction in Brd2b (~150 kD band) in brd2b MO-treated embryos (2ng total) as measured by ImageJ (FiJI) using band pixel densities (see Methods). Anti-Brd2B peptide antibody used in all immunoblot experiments in this study was raised against an antigenic epitope between NLS and ET (see Materials and Methods), and detects only the long isoform (Brd2b-L). Bottom edges of Western blots are indicated by horizontal line in ( A , C and F ). mw = Precision plus dual color molecular weight standard (BioRad); ch = Precision plus Western Chemiluminescent marker (BioRad).

Article Snippet: Three-dimensional maximum projection confocal images of the dorsal spinal cord from 3 to 6 samples per treatment group were analyzed by ImageJ FIJI software and chi-square contingency tests.

Techniques: Western Blot, High Molecular Weight, Staining, Competitive Binding Assay, Incubation, Immunohistochemical staining, Knockdown, Control, Injection, Molecular Weight, Marker